Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Association of the Functional MICA-129 Polymorphism With the Severity of Chronic Chagas Heart Disease.

Ayo CM, Oliveira AP, Camargo AV, Mattos CC, Bestetti RB, Mattos LC.

Clin Infect Dis. 2015 Oct 15;61(8):1310-3. doi: 10.1093/cid/civ540. Epub 2015 Jun 30.

2.

Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population.

Douik H, Ben Chaaben A, Attia Romdhane N, Romdhane HB, Mamoghli T, Fortier C, Boukouaci W, Harzallah L, Ghanem A, Gritli S, Makni M, Charron D, Krishnamoorthy R, Guemira F, Tamouza R.

Hum Immunol. 2009 Jan;70(1):45-8. doi: 10.1016/j.humimm.2008.10.008. Epub 2008 Nov 8.

PMID:
19000729
3.

The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.

Isernhagen A, Schilling D, Monecke S, Shah P, Elsner L, Walter L, Multhoff G, Dressel R.

Immunogenetics. 2016 Feb;68(2):109-23. doi: 10.1007/s00251-015-0884-8. Epub 2015 Nov 19.

4.

A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008.

Ashiru O, López-Cobo S, Fernández-Messina L, Pontes-Quero S, Pandolfi R, Reyburn HT, Valés-Gómez M.

Biochem J. 2013 Sep 1;454(2):295-302. doi: 10.1042/BJ20130194.

PMID:
23772752
5.

MICA variant promotes allosensitization after kidney transplantation.

Tonnerre P, Gérard N, Chatelais M, Poli C, Allard S, Cury S, Bressollette C, Cesbron-Gautier A, Charreau B.

J Am Soc Nephrol. 2013 May;24(6):954-66. doi: 10.1681/ASN.2012080814. Epub 2013 Mar 28.

6.

MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility.

Aquino-Galvez A, Pérez-Rodríguez M, Camarena A, Falfan-Valencia R, Ruiz V, Montaño M, Barrera L, Sada-Ovalle I, Ramírez R, Granados J, Pardo A, Selman M.

Hum Genet. 2009 Jun;125(5-6):639-48. doi: 10.1007/s00439-009-0666-1. Epub 2009 Apr 12.

PMID:
19363685
7.

Functional IL18 polymorphism and susceptibility to Chronic Chagas Disease.

Nogueira LG, Frade AF, Ianni BM, Laugier L, Pissetti CW, Cabantous S, Baron M, Peixoto Gde L, Borges Ade M, Donadi E, Marin-Neto JA, Schmidt A, Dias F, Saba B, Wang HT, Fragata A, Sampaio M, Hirata MH, Buck P, Mady C, Martinelli M, Lensi M, Siqueira SF, Pereira AC, Rodrigues V Jr, Kalil J, Chevillard C, Cunha-Neto E.

Cytokine. 2015 May;73(1):79-83. doi: 10.1016/j.cyto.2015.01.037. Epub 2015 Mar 2.

PMID:
25743241
8.

Description of two new MICA alleles: MICA*058 and MICA*002:03.

Zhang A, Sun Y, Viny A, Thomas D, Askar M.

Tissue Antigens. 2012 Feb;79(2):144-5. doi: 10.1111/j.1399-0039.2011.01795.x. Epub 2011 Nov 16.

PMID:
22085029
9.

Major histocompatibility complex class I chain-related gene A polymorphism and linkage disequilibrium with HLA-B alleles in Euro-Brazilians.

Ribas F, Oliveira LA, Petzl-Erler ML, Bicalho MG.

Tissue Antigens. 2008 Dec;72(6):532-8. doi: 10.1111/j.1399-0039.2008.01142.x. Epub 2008 Oct 17.

PMID:
19000131
10.

Association study of MICA gene polymorphisms with rheumatoid arthritis susceptibility in south Tunisian population.

Achour Y, Kammoun A, Ben Hamad M, Mahfoudh N, Chaabane S, Marzouk S, Keskes L, Gaddour L, Bahloul Z, Maalej A.

Int J Immunogenet. 2014 Dec;41(6):486-92. doi: 10.1111/iji.12146. Epub 2014 Sep 26.

PMID:
25256191
11.

MICA and MICB genes: can the enigma of their polymorphism be resolved?

Stephens HA.

Trends Immunol. 2001 Jul;22(7):378-85. Review.

PMID:
11429322
12.

Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease.

Boukouaci W, Al-Daccak R, Dulphy N, Lauden L, Amokrane K, Fortier C, Marzais F, Bennabi M, Peffault de Latour R, Socie G, Toubert A, Charron D, Krishnamoorthy R, Tamouza R.

Hum Immunol. 2013 Dec;74(12):1536-41. doi: 10.1016/j.humimm.2013.08.281. Epub 2013 Aug 29.

PMID:
23994587
13.

MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemia.

Viny AD, Clemente MJ, Jasek M, Askar M, Ishwaran H, Nowacki A, Zhang A, Maciejewski JP.

Haematologica. 2010 Oct;95(10):1713-21. doi: 10.3324/haematol.2010.021865. Epub 2010 May 11.

14.

Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients.

Hughes EH, Collins RW, Kondeatis E, Wallace GR, Graham EM, Vaughan RW, Stanford MR.

Tissue Antigens. 2005 Sep;66(3):195-9.

PMID:
16101830
15.

Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism.

de Oliveira AP, Bernardo CR, Camargo AV, Ronchi LS, Borim AA, de Mattos CC, de Campos Júnior E, Castiglioni L, Netinho JG, Cavasini CE, Bestetti RB, de Mattos LC.

PLoS One. 2015 Nov 23;10(11):e0141847. doi: 10.1371/journal.pone.0141847. eCollection 2015.

16.

An association between the MICA-A5.1 allele and an increased susceptibility to oral squamous cell carcinoma in Japanese patients.

Tamaki S, Sanefuzi N, Ohgi K, Imai Y, Kawakami M, Yamamoto K, Ishitani A, Hatake K, Kirita T.

J Oral Pathol Med. 2007 Jul;36(6):351-6.

PMID:
17559497
17.

Polymorphisms in genes coding for the NK-cell receptor NKG2D and its ligand MICA in recurrent miscarriage.

Hizem S, Mtiraoui N, Massaoudi S, Fortier C, Boukouaci W, Kahina A, Charron D, Mahjoub T, Tamouza R.

Am J Reprod Immunol. 2014 Dec;72(6):577-85. doi: 10.1111/aji.12314. Epub 2014 Sep 9.

PMID:
25203601
18.

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.

Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA.

Hepatology. 2008 Jan;47(1):90-6.

PMID:
18023027
19.

MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk.

Ouni N, Ben Chaaben A, Kablouti G, Lajnef M, Ayari F, Abaza H, Damak T, Harzallah L, Benammar-Elgaaeid A, Guemira F, Tamouza R.

Immunol Invest. 2017 Aug;46(6):603-614. doi: 10.1080/08820139.2017.1336175. Epub 2017 Jul 25.

PMID:
28742417
20.

BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia.

Boissel N, Rea D, Tieng V, Dulphy N, Brun M, Cayuela JM, Rousselot P, Tamouza R, Le Bouteiller P, Mahon FX, Steinle A, Charron D, Dombret H, Toubert A.

J Immunol. 2006 Apr 15;176(8):5108-16.

Supplemental Content

Support Center